Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia

Bone Marrow Transplantation

Volumn 25, Issue 2, 2000, Pages 143-146

  Konstantinidou, P ^a   Szydlo, R M ^a   Chase, A ^a   Goldman, J M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Bone marrow transplantation; Cytogenetics; Prognosis

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHROMOSOME 17; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; HUMAN; MAJOR CLINICAL STUDY; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; TRISOMY 8;

EID: 0033979617     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702133     Document Type: Article

References (15)

1. Clift RA, Anasetti C. Allografting for chronic myeloid leukaemia. Baillière's Clin Haematol 1997; 10: 319-336.
2. Przepiorka D, Thomas ED. Prognostic significance of cytogenetic abnormalities in patients with chronic myelogenous leukemia. Bone Marrow Transplant 1988; 3: 113-119.
3. Slovak ML, Kopecky KJ, Wolman SR et al. Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612). Leukemia Res 1995; 19: 381-388.
4. Savage DG, Szydlo RM, Chase A et al. Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining disease phase on probabilities of survival and relapse. Br J Haematol 1997; 99: 30-35.
5. Rooney DE, Czepulkowski BH (eds). Human Cytogenetics: A Practical Approach v.II. Oxford University Press: New York, 1992.
6. Webber L, Garson OM. Fluorodeoxyuridine synchronization of bone marrow cultures. Cancer Genet Cytogenet 1983; 8: 123-132.
7. ISCN (1995). An International System for Human Cytogenetics Nomenclature. Mitelman F (ed). S Karger: Basel, 1995.
8. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
9. Gooley TA, Leisenrin W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stats Med 1999; 18: 695-706.
10. Potter AM, Watmore AE, Cooke P et al. Significance of nonstandard Philadelphia chromosomes in chronic granulocytic leukaemia. Br J Cancer 1981; 44: 51-54.
11. O'Brien S, Thall PF, Siciliano MJ. The cytogenetics of chronic myelogenous leukaemia. Baillière's Clin Haematol 1997; 10: 259-276.
12. Mitelman F. The cytogenetic scenario of chronic myeloid leukemia. Leuk Lymphoma 1993; 11: 11-15.
13. Popenoe DW, Schaefer-Rego K, Mears JG et al. Frequent and extensive deletion during the 9;22 translocation in CML. Blood 1986; 68: 1123-1128.
14. Sinclair, PB, Leversha M, Telford N et al. Chromosome 9 deletions accompany both standard and variant Ph translocations. Br J Haematol 1998; 101 (Suppl. 1): 60 (Abstr. 151).
15. Clift RA, Buckner CD, Thomas ED. Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia. Blood 1994; 84: 4368-4373.